135 related articles for article (PubMed ID: 36179791)
21. Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor.
Brust R; Lin H; Fuhrmann J; Asteian A; Kamenecka TM; Kojetin DJ
ACS Chem Biol; 2017 Apr; 12(4):969-978. PubMed ID: 28165718
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
23. Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.
Heidari Z; Chrisman IM; Nemetchek MD; Novick SJ; Blayo AL; Patton T; Mendes DE; Diaz P; Kamenecka TM; Griffin PR; Hughes TS
Nat Commun; 2019 Dec; 10(1):5825. PubMed ID: 31862968
[TBL] [Abstract][Full Text] [Related]
24. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications.
Batista MR; Martínez L
J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113
[TBL] [Abstract][Full Text] [Related]
25. Defining a conformational ensemble that directs activation of PPARγ.
Chrisman IM; Nemetchek MD; de Vera IMS; Shang J; Heidari Z; Long Y; Reyes-Caballero H; Galindo-Murillo R; Cheatham TE; Blayo AL; Shin Y; Fuhrmann J; Griffin PR; Kamenecka TM; Kojetin DJ; Hughes TS
Nat Commun; 2018 May; 9(1):1794. PubMed ID: 29728618
[TBL] [Abstract][Full Text] [Related]
26. PPARγ signaling and emerging opportunities for improved therapeutics.
Wang S; Dougherty EJ; Danner RL
Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
[TBL] [Abstract][Full Text] [Related]
27. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.
Liberato MV; Nascimento AS; Ayers SD; Lin JZ; Cvoro A; Silveira RL; Martínez L; Souza PC; Saidemberg D; Deng T; Amato AA; Togashi M; Hsueh WA; Phillips K; Palma MS; Neves FA; Skaf MS; Webb P; Polikarpov I
PLoS One; 2012; 7(5):e36297. PubMed ID: 22649490
[TBL] [Abstract][Full Text] [Related]
28. Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells.
Abedin SA; Thorne JL; Battaglia S; Maguire O; Hornung LB; Doherty AP; Mills IG; Campbell MJ
Carcinogenesis; 2009 Mar; 30(3):449-56. PubMed ID: 19126649
[TBL] [Abstract][Full Text] [Related]
29. Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis.
Ohashi M; Gamo K; Tanaka Y; Waki M; Beniyama Y; Matsuno K; Wada J; Tenta M; Eguchi J; Makishima M; Matsuura N; Oyama T; Miyachi H
Eur J Med Chem; 2015 Jan; 90():53-67. PubMed ID: 25461311
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
[TBL] [Abstract][Full Text] [Related]
31. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
[TBL] [Abstract][Full Text] [Related]
32. Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma.
Atanasov AG; Blunder M; Fakhrudin N; Liu X; Noha SM; Malainer C; Kramer MP; Cocic A; Kunert O; Schinkovitz A; Heiss EH; Schuster D; Dirsch VM; Bauer R
PLoS One; 2013; 8(4):e61755. PubMed ID: 23630612
[TBL] [Abstract][Full Text] [Related]
33. Molecular dynamics simulations for human CAR inverse agonists.
Jyrkkärinne J; Küblbeck J; Pulkkinen J; Honkakoski P; Laatikainen R; Poso A; Laitinen T
J Chem Inf Model; 2012 Feb; 52(2):457-64. PubMed ID: 22233089
[TBL] [Abstract][Full Text] [Related]
34. Molecular Modeling of Allosteric Site of Isoform-Specific Inhibition of the Peroxisome Proliferator-Activated Receptor PPARγ.
Almahmoud S; Zhong HA
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358965
[TBL] [Abstract][Full Text] [Related]
35. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
36. Arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists covalently bind to the PPARγ ligand binding domain with a unique binding mode.
Yoshizawa M; Aoyama T; Itoh T; Miyachi H
Bioorg Med Chem Lett; 2022 May; 64():128676. PubMed ID: 35301139
[TBL] [Abstract][Full Text] [Related]
37. Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ.
dos Santos JC; Bernardes A; Giampietro L; Ammazzalorso A; De Filippis B; Amoroso R; Polikarpov I
J Struct Biol; 2015 Sep; 191(3):332-40. PubMed ID: 26185032
[TBL] [Abstract][Full Text] [Related]
38. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response.
Ren L; Konger RL
Mol Carcinog; 2019 Sep; 58(9):1589-1601. PubMed ID: 31111568
[TBL] [Abstract][Full Text] [Related]
39. Structural Basis for the Regulation of PPARγ Activity by Imatinib.
Jang JY; Kim HJ; Han BW
Molecules; 2019 Oct; 24(19):. PubMed ID: 31581474
[TBL] [Abstract][Full Text] [Related]
40. Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).
Wang J; Wang B; Zhang Y
J Biomol Struct Dyn; 2020 Feb; 38(2):398-409. PubMed ID: 31025599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
